Harte-Hanks Inc. (NYSE:HHS) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Tuesday. The brokerage currently has a $2.00 target price on the stock. Zacks Investment Research’s target price indicates a potential upside of 19.05% from the stock’s current price.

According to Zacks, “Harte-Hanks is a worldwide direct and targeted marketing company that provides marketing services and shopper advertising opportunities to local, regional, national and international consumer and business-to-business marketers. Harte-Hanks Direct Marketing improves return on its clients’ marketing investment by increasing their prospect and customer value a process of customer optimization organized around five strategic considerations: Information data collection/management — Opportunity data access/utilization — Insight data analysis/interpretation — Engagement knowledge application — Interaction program execution. Expert in integrating this process, Harte-Hanks Direct Marketing is highly skilled at tailoring solutions for each of the vertical markets it serves. “

A number of other equities research analysts also recently weighed in on HHS. Singular Research cut their price target on shares of Harte-Hanks from $4.50 to $3.80 and set a “buy” rating for the company in a report on Tuesday, June 21st. BMO Capital Markets reissued a “hold” rating on shares of Harte-Hanks in a report on Monday, July 18th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and three have given a buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $3.45.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/11/harte-hanks-inc-hhs-upgraded-by-zacks-investment-research-to-buy.html

Harte-Hanks (NYSE:HHS) traded up 0.60% during midday trading on Tuesday, reaching $1.68. 70,431 shares of the company were exchanged. Harte-Hanks has a 52-week low of $0.85 and a 52-week high of $4.35. The firm’s 50-day moving average price is $1.61 and its 200 day moving average price is $1.73. The stock’s market capitalization is $103.34 million.

Harte-Hanks (NYSE:HHS) last issued its quarterly earnings results on Tuesday, August 9th. The company reported ($0.11) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.07) by $0.04. Harte-Hanks had a negative net margin of 38.76% and a positive return on equity of 1.11%. The business earned $97.30 million during the quarter, compared to analyst estimates of $116.25 million. During the same period in the previous year, the company posted $0.04 earnings per share. Harte-Hanks’s revenue was down 10.9% compared to the same quarter last year. Equities analysts predict that Harte-Hanks will post ($0.02) earnings per share for the current year.

Hedge funds have recently bought and sold shares of the stock. JPMorgan Chase & Co. raised its stake in Harte-Hanks by 98,406.7% in the first quarter. JPMorgan Chase & Co. now owns 470,862 shares of the company’s stock worth $1,192,000 after buying an additional 470,384 shares in the last quarter. Foundry Partners LLC purchased a new stake in Harte-Hanks during the third quarter worth approximately $655,000. Renaissance Technologies LLC raised its stake in Harte-Hanks by 41.1% in the first quarter. Renaissance Technologies LLC now owns 643,200 shares of the company’s stock worth $1,627,000 after buying an additional 187,500 shares in the last quarter. Royce & Associates LP raised its stake in Harte-Hanks by 28.2% in the second quarter. Royce & Associates LP now owns 803,400 shares of the company’s stock worth $1,277,000 after buying an additional 176,830 shares in the last quarter. Finally, Paloma Partners Management Co purchased a new stake in Harte-Hanks during the second quarter worth approximately $277,000. 44.58% of the stock is owned by institutional investors.

Harte-Hanks Company Profile

Harte Hanks, Inc is a multi-channel marketing company. The Company operates through two segments, which include Customer Interaction and Trillium Software. The Customer Interaction segment provides a range of integrated, multi-channel, data-driven solutions for a range of brands around the globe. The Trillium Software segment is engaged in providing enterprise data quality solutions.

5 Day Chart for NYSE:HHS

Get a free copy of the Zacks research report on Harte-Hanks (HHS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Harte-Hanks Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Harte-Hanks Inc. and related companies with MarketBeat.com's FREE daily email newsletter.